JPWO2022246039A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022246039A5 JPWO2022246039A5 JP2023571818A JP2023571818A JPWO2022246039A5 JP WO2022246039 A5 JPWO2022246039 A5 JP WO2022246039A5 JP 2023571818 A JP2023571818 A JP 2023571818A JP 2023571818 A JP2023571818 A JP 2023571818A JP WO2022246039 A5 JPWO2022246039 A5 JP WO2022246039A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- subject
- composition
- dinitrophenoxy
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163191321P | 2021-05-20 | 2021-05-20 | |
| US63/191,321 | 2021-05-20 | ||
| US202163222841P | 2021-07-16 | 2021-07-16 | |
| US63/222,841 | 2021-07-16 | ||
| US202263307515P | 2022-02-07 | 2022-02-07 | |
| US63/307,515 | 2022-02-07 | ||
| PCT/US2022/029992 WO2022246039A1 (en) | 2021-05-20 | 2022-05-19 | Methods of treating mitochondria-related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521709A JP2024521709A (ja) | 2024-06-04 |
| JP2024521709A5 JP2024521709A5 (https=) | 2025-05-27 |
| JPWO2022246039A5 true JPWO2022246039A5 (https=) | 2025-05-27 |
Family
ID=82020295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571818A Pending JP2024521709A (ja) | 2021-05-20 | 2022-05-19 | ミトコンドリア関連障害の治療方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250177353A1 (https=) |
| EP (1) | EP4340829A1 (https=) |
| JP (1) | JP2024521709A (https=) |
| KR (1) | KR20240021827A (https=) |
| AU (1) | AU2022275935A1 (https=) |
| BR (1) | BR112023024146A2 (https=) |
| CA (1) | CA3219548A1 (https=) |
| CL (1) | CL2023003441A1 (https=) |
| GE (1) | GEAP202416398A (https=) |
| IL (1) | IL308669A (https=) |
| JO (1) | JOP20230298A1 (https=) |
| MX (1) | MX2023013688A (https=) |
| TW (1) | TW202313010A (https=) |
| WO (1) | WO2022246039A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023150759A1 (en) * | 2022-02-07 | 2023-08-10 | Rivus Pharmaceuticals, Inc. | Methods of weight loss in a subject with elevated hba1c |
| TW202515545A (zh) * | 2023-08-10 | 2025-04-16 | 大陸商深圳君聖泰生物技術有限公司 | ２，４－二硝苯酚之衍生物以及前藥、以及其組成物以及方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1098641B1 (en) | 1998-07-27 | 2016-04-27 | St. Jude Pharmaceuticals, Inc. | Chemically induced intracellular hyperthermia |
| PT3565806T (pt) | 2017-01-06 | 2022-05-19 | Rivus Pharmaceuticals Inc | Novos derivados de fenilo |
-
2022
- 2022-05-19 WO PCT/US2022/029992 patent/WO2022246039A1/en not_active Ceased
- 2022-05-19 KR KR1020237043901A patent/KR20240021827A/ko active Pending
- 2022-05-19 BR BR112023024146A patent/BR112023024146A2/pt unknown
- 2022-05-19 AU AU2022275935A patent/AU2022275935A1/en active Pending
- 2022-05-19 IL IL308669A patent/IL308669A/en unknown
- 2022-05-19 JP JP2023571818A patent/JP2024521709A/ja active Pending
- 2022-05-19 GE GEAP202416398A patent/GEAP202416398A/en unknown
- 2022-05-19 MX MX2023013688A patent/MX2023013688A/es unknown
- 2022-05-19 US US18/562,560 patent/US20250177353A1/en active Pending
- 2022-05-19 EP EP22729956.7A patent/EP4340829A1/en active Pending
- 2022-05-19 CA CA3219548A patent/CA3219548A1/en active Pending
- 2022-05-20 TW TW111118998A patent/TW202313010A/zh unknown
-
2023
- 2023-11-19 JO JOJO/P/2023/0298A patent/JOP20230298A1/ar unknown
- 2023-11-20 CL CL2023003441A patent/CL2023003441A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022062151A5 (https=) | ||
| CA3064976C (en) | Use of ligustrazine nitrone derivatives in prevention and treatment of diabetic complication diseases | |
| KR20160136451A (ko) | Nafld 및 nash 의 치료 | |
| Kiuchi et al. | Long-term use of ipragliflozin improved cardiac sympathetic nerve activity in a patient with heart failure: a case report | |
| CN108125937A (zh) | 亚精胺在预防和治疗脂肪肝和2型糖尿病中的用途 | |
| Kruse et al. | Eight weeks of nitrate supplementation improves blood flow and reduces the exaggerated pressor response during forearm exercise in peripheral artery disease | |
| Gursoy et al. | New-onset acute heart failure after intravenous glucocorticoid pulse therapy in a patient with Graves' ophthalmopathy | |
| EP3616697B1 (en) | Use of a pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition comprising berberine and oryzanol | |
| JPWO2022246039A5 (https=) | ||
| US20250177353A1 (en) | Methods of treating mitochondria-related disorders | |
| WO2024112663A1 (en) | Deuterium enriched phenyl derivatives for treating mitochondriarelated disorders or conditions | |
| US9101537B2 (en) | Compositions and methods for the prevention and treatment of cardiovascular diseases | |
| CN101229373B (zh) | 治疗糖尿病肾病的药物组合物 | |
| Collet-Gaudillat et al. | Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: a case report | |
| Thakur et al. | Changes in the Early Stages of Obesity | |
| CN102895270A (zh) | 红曲、银杏叶组合物在防治糖尿病并发症方面的应用 | |
| US20250134865A1 (en) | Methods of weight loss in a subject with elevated hba1c | |
| JPH04210644A (ja) | 高血圧症治療剤 | |
| JP2024511326A (ja) | トルセミドおよびクロモリンを含む代謝疾患予防または治療用組成物 | |
| Pomeranze et al. | Therapy in intermittent claudication | |
| KR100519950B1 (ko) | 알파 리포산을 유효성분으로 함유하는 혈관 내 지질류증가 억제용 조성물 | |
| Heidari | Metabolic syndrome: Pharmacological strategies and challenges | |
| JPWO2023150767A5 (https=) | ||
| Jaganmohan | JCD | |
| JP2007302633A (ja) | 繊維質の燃焼時に発生する煙に含まれる有害成分によって引き起こされる障害の予防乃至治療剤 |